DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $150,000 | -52.7% | 7,465 | -12.1% | 0.00% | -50.0% |
| Q2 2021 | $317,000 | +66.0% | 8,497 | +13.8% | 0.00% | +100.0% |
| Q1 2021 | $191,000 | -1.0% | 7,465 | -14.6% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +52.0% | 8,744 | +24.1% | 0.00% | 0.0% |
| Q3 2020 | $127,000 | -29.1% | 7,046 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $179,000 | +118.3% | 7,046 | +56.9% | 0.00% | +100.0% |
| Q1 2020 | $82,000 | +10.8% | 4,491 | +33.5% | 0.00% | 0.0% |
| Q4 2019 | $74,000 | +54.2% | 3,363 | 0.0% | 0.00% | – |
| Q3 2019 | $48,000 | +37.1% | 3,363 | +52.0% | 0.00% | – |
| Q2 2019 | $35,000 | +9.4% | 2,212 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -13.5% | 2,212 | -36.1% | 0.00% | – |
| Q4 2018 | $37,000 | +311.1% | 3,459 | +512.2% | 0.00% | – |
| Q3 2018 | $9,000 | – | 565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |